Stockscreener 앱 받기
2.39
1.65%
-0.04
시간 외 거래:
2.37
-0.02
-0.84%
전일 마감가:
$2.43
열려 있는:
$2.47
하루 거래량:
2.71M
Relative Volume:
1.36
시가총액:
$160.51M
수익:
-
순이익/손실:
$-13.14M
주가수익비율:
-7.8207
EPS:
-0.3056
순현금흐름:
$-13.11M
1주 성능:
+1.70%
1개월 성능:
-11.15%
6개월 성능:
-18.15%
1년 성능:
-6.27%
1일 변동 폭
$2.30
$2.53
1주일 범위
$2.23
$2.69
52주 변동 폭
$1.6001
$4.67
Microbot Medical Inc Stock (MBOT) Company Profile
명칭
Microbot Medical Inc
전화
908-938-5561
주소
25 RECREATION PARK DR SUITE 108, HINGHAM, MA
Compare MBOT vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MBOT
Microbot Medical Inc
|
2.39 | 163.19M | 0 | -13.14M | -13.11M | -0.3056 |
ISRG
Intuitive Surgical Inc
|
468.36 | 165.94B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
155.52 | 44.30B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
80.73 | 38.96B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
47.93 | 38.69B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
228.80 | 33.61B | 5.40B | 1.49B | 1.78B | 10.12 |
Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-10 | 개시 | B. Riley Securities | Buy |
| 2025-12-03 | 개시 | Roth Capital | Buy |
| 2020-01-13 | 재확인 | H.C. Wainwright | Buy |
| 2019-12-24 | 재확인 | H.C. Wainwright | Buy |
| 2018-01-31 | 개시 | Ladenburg Thalmann | Buy |
Microbot Medical Inc 주식(MBOT)의 최신 뉴스
Microbot Medical (MBOT) price target increased by 12.50% to 7.65 - MSN
Microbot Medical Begins Full U.S. Launch of LIBERTY System - Yahoo Finance
Microbot Medical® to Highlight Commercial Achievements - GlobeNewswire
Microbot Medical to present at Needham healthcare conference - Investing.com
MBOT Reiterated by HC Wainwright & Co. -- Price Target Maintained at $12 - GuruFocus
Microbot Medical to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference - Bitget
Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference - Yahoo Finance
Microbot Showcases LIBERTY Robotic System Full Release - TipRanks
Microbot to Spotlight LIBERTY Full Market Release, CEO to Present at Needham Conference - TradingView — Track All Markets
Microbot Medical (NASDAQ: MBOT) to spotlight LIBERTY robotic system FMR - Stock Titan
H.C. Wainwright Maintains Microbot Medical(MBOT.US) With Buy Rating, Maintains Target Price $12 - Moomoo
H.C. Wainwright reiterates Microbot Medical stock rating on full market release - Investing.com
Emory Healthcare IRs 1st in the world to use newly approved robotic system for liver, prostate procedures - Radiology Business
Bear Alert: Is Microbot Medical Inc stock a value trap2026 Final Week & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Microbot Medical (MBOT) Expands LIBERTY Robot System Release in U.S. - GuruFocus
Microbot Medical launches full market release of robotic system By Investing.com - Investing.com South Africa
Microbot Medical Launches Full Market Release of FDA-Cleared LIBERTY Endovascular Robotic System in the U.S - Minichart
Microbot Medical launches full market release of robotic system - Investing.com
Microbot Medical launches full U.S. LIBERTY system rollout - TipRanks
Microbot Medical begins U.S. full market release of LIBERTY after successful limited release - TradingView — Track All Markets
LIBERTY robot rollout widens for Microbot Medical (NASDAQ: MBOT) - Stock Titan
Only FDA-cleared single-use endovascular robot expands U.S. rollout - Stock Titan
Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting - Sahm
Microbot Medical Commences Full Market Release (FMR) of the LIBERTY Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting - Moomoo
Microbot Medical Inc. Files Form 8-K – Company Details, NASDAQ Listing, and Contact Information (April 10, 2026) - Minichart
Microbot Medical Expands At-The-Market Equity Offering Program - TipRanks
Form 424B5 Microbot Medical Inc. - StreetInsider
Microbot Medical (MBOT) files ATM to raise up to $39.2M for LIBERTY® development - Stock Titan
Microbot Medical prices ATM program up to $39.2M, files prospectus supplement - TradingView — Track All Markets
Microbot Medical (NASDAQ: MBOT) outlines $39,230,691 at-the-market stock plan - Stock Titan
Microbot Medical Inc (MBOT) Balance Sheet - TradingKey
MBOT Stock Price, Quote & Chart | MICROBOT MEDICAL INC (NASDAQ:MBOT) - ChartMill
Aug Gainers: Does Microbot Medical Inc have declining or rising EPSEarnings Overview Summary & Weekly Chart Analysis and Guides - baoquankhu1.vn
Symbol lookup from Yahoo Finance - Yahoo Finance UK
MBOT Technical Analysis & Stock Price Forecast - Intellectia AI
MBOT Technical Analysis | Trend, Signals & Chart Patterns | MICROBOT MEDICAL INC (NASDAQ:MBOT) - ChartMill
Dividend Watch: Is Microbot Medical Inc stock a value trap2026 Biggest Moves & Precise Trade Entry Recommendations - baoquankhu1.vn
Pullback Watch: Will Microbot Medical Inc outperform its industry peers2026 Final Week & Daily Stock Trend Watchlist - baoquankhu1.vn
[Form 4] Microbot Medical Inc. Insider Trading Activity - Stock Titan
Director at Microbot Medical (NASDAQ: MBOT) gets 10,000 options - Stock Titan
Director at Microbot Medical (NASDAQ: MBOT) awarded 10,000 stock options at $2.37 strike - Stock Titan
Director at Microbot Medical (NASDAQ: MBOT) granted 10,000 stock options at $2.37 - Stock Titan
Microbot Medical director granted 10,000 options | MBOT Insider Trading - Stock Titan
Microbot Medical highlights radiation reduction amid AMA policy shift - Investing.com
Microbot Medical (HAM:CY9D) Gross Property, Plant and Equipment : €1.33 Mil (As of Dec. 2025) - GuruFocus
Microbot Medical Inc. (MBOT) stock price, news, quote and history - Yahoo Finance Australia
Microbot Medical Inc. (NASDAQ:MBOT) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Microbot Medical Inc Stock: Pioneering Robotics in Minimally Invasive Procedures for Future Medical - AD HOC NEWS
Microbot Medical (HAM:CY9D) PE Ratio : At Loss (As of Mar. 31, 2026) - GuruFocus
Microbot Medical (HAM:CY9D) Net Income (Discontinued Operat - gurufocus.com
Microbot Medical (HAM:CY9D) Degree of Operating Leverage : 0.00 (As of Dec. 2025) - GuruFocus
Microbot Medical Inc (MBOT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.06%
1.84%
자본화:
|
볼륨(24시간):